{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:14:54Z","timestamp":1790007294120,"version":"4.0.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf00684870","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T07:29:03Z","timestamp":1101713343000},"page":"S89-S95","source":"Crossref","is-referenced-by-count":29,"title":["Epipodophyllotoxins in the treatment of childhood cancer"],"prefix":"10.1007","volume":"34","author":[{"given":"Gaston K.","family":"Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Crist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1200\/JCO.1985.3.6.789","volume":"3","author":"M Abromowitch","year":"1985","unstructured":"Abromowitch M, Bowman WP, Ochs J, Rivera G (1985) Etoposide (VP16) with prednisone and vincristine for treatment of refractory acute lymphoblastic leukemia. J Clin Oncol 3: 789","journal-title":"J Clin Oncol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1200\/JCO.1987.5.12.1952","volume":"5","author":"JL Bernard","year":"1987","unstructured":"Bernard JL, Phillip T, Zucker JM, Frappaz D, Robert A, Margueritte G, Boilletot A, Philippe N, Lutz P, Roche H, Pinkerton R (1987) Sequential cisplatin\/VM-26 and vincristine\/cyclophosphamide\/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross-resistant regimen? J Clin Oncol 5: 1951","journal-title":"J Clin Oncol"},{"key":"CR3","first-page":"977","volume":"63","author":"WA Bleyer","year":"1979","unstructured":"Bleyer WA, Krivit W, Chard RL, Hammond D (1979) Phase II study of VM26 in acute leukemia, neuroblastoma and other refractory childhood malignancies: A report from the Children's Cancer Study Group. Cancer Treat Rep 63: 977","journal-title":"Cancer Treat Rep"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1200\/JCO.1991.9.9.1599","volume":"9","author":"LC Bowman","year":"1991","unstructured":"Bowman LC, Hancock ML, Santana VM, Hayes FA, Kun L, Parham DM, Furman WL, Rao BN, Green AA, Crist WM (1991) Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St. Jude Children's Research Hospital Experience, 1962 to 1988. J Clin Oncol 9: 1599","journal-title":"J Clin Oncol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1182\/blood.V72.4.1286.1286","volume":"72","author":"GR Buchanan","year":"1988","unstructured":"Buchanan GR, Rivera GK, Boyett JM, Chauvenet AR, Crist WM, Vietti TJ (1988) Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group study. Blood 72: 1286","journal-title":"Blood"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/1097-0142(19910701)68:1<48::AID-CNCR2820680110>3.0.CO;2-X","volume":"68","author":"GR Buchanan","year":"1991","unstructured":"Buchanan GR, Boyett JM, Pollock BH, Smith DS, Yanossky RA, Kimm TH, Wharm MD, Crist WM, Vietti TJ, Johnson W, Rivera GK (1991) Improved treatment results in boys with isolated overt testicular relapse during or shortly following initial the rapy of acute lymphoblastic leukemia: a Pediatric Oncology Group (POG) study. Cancer 68: 48","journal-title":"Cancer"},{"key":"CR7","first-page":"1755","volume":"63","author":"RL Chard","year":"1979","unstructured":"Chard RL, Krivit W, Bleyer WA, Hammond D (1979) Phase II study of VP 16-213 in childhood malignant disease: a Children's Cancer Study Group report. Cancer Treat Rep 63: 1755","journal-title":"Cancer Treat Rep"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"13560","DOI":"10.1016\/S0021-9258(18)90729-5","volume":"259","author":"GL Chen","year":"1984","unstructured":"Chen GL, Yang L, Rowe TC, Halligan BD, Tewey KM, Liu LF (1984) Nonintercalative antitumor drugs interfere with the breakage-reunion of mammalian DNA topoisomerase II. J Biol Chem 259: 13560","journal-title":"J Biol Chem"},{"key":"CR9","first-page":"6712","volume":"51","author":"G Cimino","year":"1991","unstructured":"Cimino G, Mori DT, Canaani O, Williams K, Crist WM, Katzav S, Cannizzaro L, Lange B, Nowell PC, Croce CM, Canaani E (1991) Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(q22;q23), and t(11;19)(q23;q13) chromosome translocations. Cancer Res 51: 6712","journal-title":"Cancer Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199309233291311","volume":"329","author":"ML Cleary","year":"1993","unstructured":"Cleary ML (1993) A promiscuous oncogene in acute leukemia (editorial). N Engl J Med 329: 958","journal-title":"N Engl J Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood.V66.5.1110.1110","volume":"66","author":"GV Dahl","year":"1985","unstructured":"Dahl GV, Rivera G, Pui C-H, Mirro J, Ochs J, Kalwinsky D, Abromowitch M, Look AT, Murphy SB (1985) A novel treatment for childhood lymphoblastic non-Hodgkin's lumphoma: early and intermittent use of teniposide plus cytarabine. Blood 66: 1110","journal-title":"Blood"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.1987.5.7.1015","volume":"5","author":"GV Dahl","year":"1987","unstructured":"Dahl GV, Rivera GK, Look AT, Hustu O, Kalwinsky DK, Abromowitch M, Mirro J, Ochs J, Murphy SB, Dodge RK, Pui C-H (1987) Teniposide plus cytarabine improves outcome in childhood acute lumphoblastic leukemia presenting with a leukocyte count ?100\u00d7109\/L. J Clin Oncol 5: 1015","journal-title":"J Clin Oncol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/bjc.1989.165","volume":"59","author":"F deVathaire","year":"1989","unstructured":"deVathaire F, Francois P, Hill C, Schweisguth O, Rodary C, Sarrazin D, Oberlin O, Beurtheret C, Dutreix A, Flamant R (1989) Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood. Br J Cancer 59: 792","journal-title":"Br J Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood.V79.4.871.bloodjournal794871","volume":"79","author":"SM Eguiguren","year":"1992","unstructured":"Eguiguren SM, Schell MJ, Crist WM, Kunkel K, Rivera GK (1992) Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood 79: 871","journal-title":"Blood"},{"key":"CR15","first-page":"71","volume":"260","author":"WE Evans","year":"1992","unstructured":"Evans WE, Rodman JH, Relling MV, Petros WP, Stewart CF, Pui C-H, Rivera GK (1992) Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia. J Pharmacol Exp Ther 260: 71","journal-title":"J Pharmacol Exp Ther"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/0006-2952(90)90227-C","volume":"40","author":"DW Fry","year":"1990","unstructured":"Fry DW (1990) Cytotoxic synergism between trimetrexate and etoposide: evidence that trimetrexate potentiates etoposide-induced protein-associated DNA strand breaks in L-1210 leukemia cells through alterations in intracellular ATP concentrations. Biochem Pharmacol 40: 1981","journal-title":"Biochem Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1182\/blood.V74.6.2088.2088","volume":"74","author":"GA Gagnon","year":"1989","unstructured":"Gagnon GA, Childs CC, LeMaistre A, Keating M, Cork A, Trujillo JM, Nellis K, Freireich E, Stass SA (1989) Molecular heterogeneity in acute leukemia lineage switch. Blood 74: 2088","journal-title":"Blood"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1200\/JCO.1990.8.4.661","volume":"8","author":"JC Gentet","year":"1990","unstructured":"Gentet JC, Patte C, Quintana E, Bergeron C, Rubie H, Pein F, Demaille MC, Philip T, Raybaud C (1990) Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology. J Clin Oncol 8: 661","journal-title":"J Clin Oncol"},{"key":"CR19","first-page":"439","volume":"66","author":"JH Goldie","year":"1982","unstructured":"Goldie JH, Coldman AJ, Gudauskas GA (1982) Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 66: 439","journal-title":"Cancer Treat Rep"},{"key":"CR20","first-page":"71","volume":"17","author":"FA Greco","year":"1980","unstructured":"Greco FA, Johnson DH, Hainsworth JD (1980) Chronic daily administration of oral etoposide. Semin Oncol 17: 71","journal-title":"Semin Oncol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1200\/JCO.1988.6.2.351","volume":"6","author":"JL Grem","year":"1988","unstructured":"Grem JL, Hoth DF, Leyland-Jones, King SA, Ungerleider RS, Wittes RE (1988) Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal disease. J Clin Oncol 6: 351","journal-title":"J Clin Oncol"},{"key":"CR22","first-page":"3766","volume":"37","author":"FA Hayes","year":"1977","unstructured":"Hayes FA, Green AA, Mauer AM (1977) Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma. Cancer Res 37: 3766","journal-title":"Cancer Res"},{"key":"CR23","first-page":"439","volume":"69","author":"FA Hayes","year":"1985","unstructured":"Hayes FA, Abromowitch M, Green AA (1985) Allergic reactions to teniposide in patients with neurobalstoma and lumphoid malignancies. Cancer Treat Rep 69: 439","journal-title":"Cancer Treat Rep"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.1993.11.6.1080","volume":"6","author":"MM Hudson","year":"1993","unstructured":"Hudson MM, Weinstein HJ, Donaldson SS, Greenwald C, Kun L, Tarbell NJ, Humphrey WA, Rupp C, Marina NM, Wilimas J, Link MP (1993) Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. J Clin Oncol 6: 1080","journal-title":"J Clin Oncol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1182\/blood.V81.12.3197.3197","volume":"12","author":"SP Hunger","year":"1993","unstructured":"Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML (1993) HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood 12: 3197","journal-title":"Blood"},{"key":"CR26","first-page":"39","volume":"6","author":"CA Hurwitz","year":"1992","unstructured":"Hurwitz CA, Krance R, Schell MJ, Santana VM, Brenner MK, Ribeiro R, Roberts WM, Mahmoud H, Belt J, Crom W, Shearer PD, Mirro J Jr (1992) Current strategies for treatment of acute myeloid leukemia at St. Jude Children's Research Hospital. Leukemia 6: 39","journal-title":"Leukemia"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1200\/JCO.1988.6.7.1134","volume":"7","author":"D Kalwinsky","year":"1988","unstructured":"Kalwinsky D, Mirro J Jr, Schell M, Behm F, Mason C, Dahl GV (1988) Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regiment including etoposide. J Clin Oncol 7: 1134","journal-title":"J Clin Oncol"},{"key":"CR28","first-page":"935","volume":"70","author":"BA Kamen","year":"1986","unstructured":"Kamen BA, Casper J, Lauer S, Camitta BM, Holcenberg JS (1986) Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine. Cancer Treat Rep 70: 935","journal-title":"Cancer Treat Rep"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/1097-0142(19910215)67:4<1070::AID-CNCR2820670434>3.0.CO;2-X","volume":"67","author":"SJ Kellie","year":"1991","unstructured":"Kellie SJ, Crist WM, Pui C-H, Crone M, Fairclough D, Rodman JH, Rivera GK (1991) Hypersensitivity reactions to epipodophyllotoxins in children with acute lumphoblastic leukemia. Cancer 67: 1070","journal-title":"Cancer"},{"key":"CR30","first-page":"805","volume":"324","author":"SE Lipschultz","year":"1991","unstructured":"Lipschultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP (1991) Late cardiac effects of doxorubicin therapy for acute lumphoblastic leukemic in childhood. N Engl J Med 324: 805?815","journal-title":"N Engl J Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1021\/bi00670a004","volume":"25","author":"JD Loike","year":"1976","unstructured":"Loike JD, Horwitz SB (1976) Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells. Biochemistry 25: 5443","journal-title":"Biochemistry"},{"key":"CR32","first-page":"3106","volume":"45","author":"BH Long","year":"1985","unstructured":"Long BH, Musial ST, Brattain ME (1985) Single and doublestrand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. Cancer Res 45: 3106","journal-title":"Cancer Res"},{"key":"CR33","first-page":"995","volume":"65","author":"AT Look","year":"1981","unstructured":"Look AT, Dahl GV, Kalwinsky DK, Senzer N, Mason C, Rivera G (1981) Effective reminssion induction of refractory childhood acute monlymphocytic leukemia by VP 16-213 plus 5-azacytidine. Cancer Treat Rep 65: 995","journal-title":"Cancer Treat Rep"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1200\/JCO.1993.11.3.554","volume":"11","author":"NM Marina","year":"1993","unstructured":"Marina NM, Rodman J, Shema SJ, Bowman LC, Douglass E, Furman W, Santana VM, Hudson M, Wilimas J, Meyer W, Madden T, Pratt C (1993) Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors. J Clin Oncol 11: 554","journal-title":"J Clin Oncol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00263133","volume":"25","author":"J Mirro","year":"1989","unstructured":"Mirro J, Kalwinsky DK, Grier HE, Santana VM, Mason C, Murphy SB, Dahl GV (1989) Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine. Cancer Chemother Pharmacol 25: 123","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1200\/JCO.1987.5.8.1191","volume":"5","author":"JS Miser","year":"1987","unstructured":"Miser JS, Kinsella TJ, Triche TJ, Tsokos M, Jarosinski P, Forquer R, Wesley R, Magrath I (1987) Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol 5: 1191","journal-title":"J Clin Oncol"},{"key":"CR37","first-page":"158","volume":"11","author":"TJ Moss","year":"1989","unstructured":"Moss TJ, Strauss LC, Das L, Feig SA (1989) Secondary leukemia following successful treatment of Wilms' tumor. Am J Pediatr Hematol Oncol 11: 158","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/1097-0142(19901015)66:8<1671::AID-CNCR2820660803>3.0.CO;2-E","volume":"66","author":"J Ochs","year":"1991","unstructured":"Ochs J, Rivera GK, Pollock DH, Buchanan GR, Crist WM, Freeman AI (1991) Teniposide and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lumphoblastic leukemia: a Pediatric Oncology Group (POG) study. Cancer 66: 1671","journal-title":"Cancer"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1991.9.1.139","volume":"9","author":"J Ochs","year":"1991","unstructured":"Ochs J, Rodman J, Abromowitch M, Kavanaugh R, Harris M, Yalowich J, Rivera GK (1991) A phase II study of combined methotrexate and teniposide infusions prior to reinduction therapy in relapsed childhood acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol 9: 139","journal-title":"J Clin Oncol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood.V64.4.875.875","volume":"64","author":"LF Odom","year":"1984","unstructured":"Odom LF, Gordon E (1984) Acute monoblastic leukemia in infancy and early childhood: successful treatment with an epipodophyllotoxin. Blood 64: 875","journal-title":"Blood"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM198503143121106","volume":"312","author":"PJ O'Dwyer","year":"1985","unstructured":"O'Dwyer PJ, Leyland-Jones B, Alonso MT, Marsoni S, Wittes RE (1985) Etoposide (VP-16-213) ? current status of an active anticancer drug. N Engl J Med 312: 692","journal-title":"N Engl J Med"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.1991.9.1.123","volume":"9","author":"C Patte","year":"1991","unstructured":"Patte C, Philip T, Rodary C, Zucker J-M, Behrendt H, Gentet J-C, Lamagn\u00e9re J-P, Otten J, Dufillot D, Pein F, Caillou B, Lemerle J (1991) High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9: 123","journal-title":"J Clin Oncol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0140-6736(91)90490-G","volume":"338","author":"J Pedersen-Bjergaard","year":"1991","unstructured":"Pedersen-Bjergaard J, Daugaard G, Hansen SW, Phillip P, Larsen SO, Rorth M (1991) Increased risk of myelodysplasia and leukemia after etoposide, cisplatin and bleomycin for germ-cell tumors. Lancet 338: 359","journal-title":"Lancet"},{"key":"CR44","first-page":"1975","volume":"12","author":"J Pedersen-Bjergaard","year":"1993","unstructured":"Pedersen-Bjergaard J, Philip P, Larsen SO, Anderson M, Daugaard G, Ersb\u00f8\u00f8ll J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC, Specht L, \u00d8sterline K (1993) Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 12: 1975","journal-title":"Leukemia"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.1987.5.6.941","volume":"5","author":"T Philip","year":"1987","unstructured":"Philip T, Ghalie R, Pinkerton R, Zucker JM, Bernard JL, Leverger G, Harmann O (1987) A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 5: 941","journal-title":"J Clin Oncol"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1200\/JCO.1991.9.6.1037","volume":"9","author":"T Phillip","year":"1991","unstructured":"Phillip T, Zucker JM, Bernard JL, Lutz P, Bordigoni P, Plouvier E, Robert A, Roche H, Gouillet G, Bouffet E, Michon J, Lopez M, Vilcoq JM, Gentet JC, Philip I, Ladenstein R, Favrot M, Chauvin F (1991) Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup? J Clin Oncol 9: 1037","journal-title":"J Clin Oncol"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJM198907203210302","volume":"321","author":"C-H Pui","year":"1989","unstructured":"Pui C-H, Behm FG, Raimondi SC, Dodge RK, George SL, Rivera GK, Mirro J, Kalwinsky DK, Dahl GV, Murphy SB, Crist WM, William DL (1989) Secondary acute myeloid leukemia in children treated for acute 1 ymphoid leukemia. N Engl J Med 321: 136","journal-title":"N Engl J Med"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1056\/NEJM198912283212612","volume":"321","author":"C-H Pui","year":"1989","unstructured":"Pui C-H, Rivera GK, Crist WM (1989) Potential long-term toxicities in children treated for acute lymphoblastic leukemia. Letter to the editor. N Engl J Med 321: 1830","journal-title":"N Engl J Med"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM199112123252402","volume":"325","author":"C-H Pui","year":"1991","unstructured":"Pui C-H, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi CS, Head DR, Behm FG, Mahmound MH, Sandlund JT, Crist WM (1991) Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 325: 1682","journal-title":"N Engl J Med"},{"key":"CR50","first-page":"150","volume":"6","author":"C-H Pui","year":"1992","unstructured":"Pui C-H, Simone JV, Hancock ML, Evans WE, Williams DL, Bowman WP, Dahl GV, Didge RK, Ochs J, Abromowitch M, Rivera GK (1992) Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: longterm results of St. Jude total therapy study X. Leukemia 6: 150","journal-title":"Leukemia"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1200\/JCO.1990.8.8.1380","volume":"8","author":"SC Raimondi","year":"1990","unstructured":"Raimondi SC, Behm FG, Roberson PK, Williams DL, Pui C-H, Crist WM, Look AT, Rivera GK (1990) Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 8: 1380","journal-title":"J Clin Oncol"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/oxfordjournals.annonc.a058121","volume":"3","author":"MJ Ratain","year":"1992","unstructured":"Ratain MJ, Rowley JD (1992) Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II. From the bedside to the target genes. Ann Oncol 3: 107","journal-title":"Ann Oncol"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood.V70.5.1412.1412","volume":"70","author":"MJ Ratain","year":"1990","unstructured":"Ratain MJ, Kamiver LS, Bitran JD, Larson RA, LeBeau MM, Skosey C, Purl S, Hoffman PC, Wade J, Vardiman W, Daly K, Rowley JD, Golomb HM (1990) Acute non-lumphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell-carcinoma of the lung. Blood 70: 1412","journal-title":"Blood"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood.V80.10.2471.2471","volume":"80","author":"A Reiter","year":"1992","unstructured":"Reiter A, Schrappe M, Ludwig W-D, Lampert F, Harbott J, Henze G, Niemeyer CM, Gadner H, M\u00fcller-Weihrich S, Ritter J, Odenwald E, Riehm H (1992) Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood 80: 2471","journal-title":"Blood"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1200\/JCO.1988.6.2.191","volume":"6","author":"GK Rivera","year":"1988","unstructured":"Rivera GK (1988) The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia (editorial). J Clin Oncol 6: 191","journal-title":"J Clin Oncol"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1053-4296(05)80055-4","volume":"2","author":"GK Rivera","year":"1992","unstructured":"Rivera GK, Evans WE (1992) Clinical trials of teniposide (VM-26) in childhood acute lymphocytic leukemia. Semin Oncol 2: 51","journal-title":"Semin Oncol"},{"key":"CR57","first-page":"743","volume":"59","author":"G Rivera","year":"1975","unstructured":"Rivera G, Avery T, Pratt C (1975) 4?-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-?-d-glucopyranoside) (NSC-122819; VM-26) and 4?-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-?-d-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations. Cancer Chemother Rep 59: 743","journal-title":"Cancer Chemother Rep"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0014-2964(75)90099-7","volume":"11","author":"G Rivera","year":"1975","unstructured":"Rivera G, Avery T, Roberts D (1975) Response of L-1210 to combinations of cytosine arabinoside and VM 26 or VP 16-213. Eur J Cancer 11: 639","journal-title":"Eur J Cancer"},{"key":"CR59","first-page":"1243","volume":"61","author":"G Rivera","year":"1977","unstructured":"Rivera G, Green AG, Hayes A, Avery T, Pratt C (1977) Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma. Cancer Treat Rep 61: 1243","journal-title":"Cancer Treat Rep"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/1097-0142(19800315)45:6<1284::AID-CNCR2820450604>3.0.CO;2-Q","volume":"46","author":"G Rivera","year":"1980","unstructured":"Rivera G, Aur RJ, Dahl GV, Pratt CV, Wood A, Avery T (1980) Combined VM26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia. Cancer 46: 1284","journal-title":"Cancer"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/1097-0142(19801015)46:8<1727::AID-CNCR2820460804>3.0.CO;2-4","volume":"46","author":"G Rivera","year":"1980","unstructured":"Rivera G, Dahl GV, Bowman WP, Avery TL, Wood A, Aur RJ (1980) VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia. Cancer 46: 1727","journal-title":"Cancer"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0305-7372(82)80078-9","volume":"9","author":"G Rivera","year":"1982","unstructured":"Rivera G, Bowman WP, Look AT, Evans WE, Kalwinsky D, Dahl GV (1982) Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhood. Cancer Treat Rev 9: 53","journal-title":"Cancer Treat Rev"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/mpo.2950100503","volume":"10","author":"G Rivera","year":"1982","unstructured":"Rivera G, Bowman WP, Murphy SB, Dahl GV, Aur RJ, Kalwinsky DK, Wood A, Stagner S, Avery TL (1982) VM-26 with prednisone and vincristine for treatment of refractory actue lymphocytic leukemia. Med Pediatr Oncol 10: 439","journal-title":"Med Pediatr Oncol"},{"key":"CR64","first-page":"213","volume-title":"Leukemia research: advances in cell biology and treatment","author":"G Rivera","year":"1983","unstructured":"Rivera G, Dahl GV, Murphy SB, Bowman WP, Abromowitch M, Ochs J, Pui C-H, Kalwinsky DK, Avery TL, George SL, Simone JV (1983) The epipodophyllotoxin VM-26 in treatment of highrisk acute lymphoblastic leukemia: rationale and early results. In: Murphy SB, Gilbert JR (eds) Leukemia research: advances in cell biology and treatment. Elsevier, Amsterdam, p 213"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1200\/JCO.1985.3.2.201","volume":"3","author":"G Rivera","year":"1985","unstructured":"Rivera G, Evans WE, Kalwinsky DK, Mirro J, Ochs J, Dow LW, Abromowitch M, Pui CH, Dahl GV, Look AT, Crone M, Murphy SB (1985) Unexpectedly severe toxicity from high-dose methotrexate in early treatment of chil dhood lymphoblastic leukemia. J Clin Oncol 3: 201","journal-title":"J Clin Oncol"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM198607313150501","volume":"315","author":"GK Rivera","year":"1986","unstructured":"Rivera GK, Buchanan G, Boyett JM, Camitta B, Ochs J, Kalwinsky D, Amylon M, Vietti TJ, Crist WM (1986) Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group study. N Engl J Med 315: 273","journal-title":"N Engl J Med"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0140-6736(91)90733-6","volume":"337","author":"GK Rivera","year":"1991","unstructured":"Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui C-H, Abromowitch M, Mirro J, Ochs JS, Look AT, Williams DL, Murphy SB, Dahl GV, Kalwinsky DK, Evans WE, Kun LE, Simone JV, Crist WM (1991) Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 337: 61","journal-title":"Lancet"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199310283291801","volume":"329","author":"GK Rivera","year":"1993","unstructured":"Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM (1993) Treatment of acute lymphoblastic leukemia ? 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med 329: 1289","journal-title":"N Engl J Med"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1993.11.8.1624","volume":"8","author":"GK Rivera","year":"1993","unstructured":"Rivera GK, Pui C-H, Crist WM (1993) The epipodophyllotoxins: both sides of the coin. J Clin Oncol 8: 1624","journal-title":"J Clin Oncol"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/1097-0142(19930515)71:10+<3400::AID-CNCR2820711744>3.0.CO;2-O","volume":"10","author":"GK Rivera","year":"1993","unstructured":"Rivera GK, Pui C-H, Santana VM, Hancock ML, Mahmoud H, Sandlund JT, Ribeiro RC, Furman W, Marina N, Crist WM (1993) Progress in the treatment of adolescents with acute lymphoblastic leukemia. Cancer 10: 3400","journal-title":"Cancer"},{"key":"CR71","first-page":"5857","volume":"44","author":"W Ross","year":"1984","unstructured":"Ross W, Rowe T, Glisson B, Yalowitch J, Liu LE (1984) Role of topoisomerase II in mediating epipodophyllotixin-induced DNA cleavage. Cancer 44: 5857","journal-title":"Cancer"},{"key":"CR72","first-page":"713","volume":"71","author":"DH Ryan","year":"1987","unstructured":"Ryan DH, Kopecky J, Head D, Gumbart CN, Grever MR, Karanes C, Weick JK, Coltman CA Jr (1987) Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group study. Cancer Treat Rep 71: 713","journal-title":"Cancer Treat Rep"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1182\/blood.V81.3.602.602","volume":"81","author":"PD Sadowitz","year":"1993","unstructured":"Sadowitz PD, Smith SD, Shuster J, Wharam MD, Buchanan GR, Rivera GK (1993) Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) study. Blood 81: 602","journal-title":"Blood"},{"key":"CR74","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/JCO.1993.11.6.1039","volume":"11","author":"C Sandoval","year":"1993","unstructured":"Sandoval C, Pui C-H, Bowman LC, Heaton D, Hurwitz CA, Raimondi SC, Behm FG, Head DR (1993) Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation. J Clin Oncol 11: 1039","journal-title":"J Clin Oncol"},{"key":"CR75","first-page":"457","volume":"10","author":"VM Santana","year":"1992","unstructured":"Santana VM, Schell MJ, Williams R, Bowman LC, Thompson EI, Brenner MK, Mirro J Jr (1992) Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors. Bone Marrow Transplant 10: 457","journal-title":"Bone Marrow Transplant"},{"key":"CR76","first-page":"1321","volume":"70","author":"GF Sanz","year":"1986","unstructured":"Sanz GF, Sanz MA, Rafecas FJ, Martinez JA, Martin-Aragones G, Marty MS (1986) Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia. Cancer Treat Rep 70: 1321","journal-title":"Cancer Treat Rep"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1200\/JCO.1984.2.7.742","volume":"2","author":"EA Shafford","year":"1984","unstructured":"Shafford EA, Rogers DW, Pritchard J (1984) Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26. J Clin Oncol 2: 742","journal-title":"J Clin Oncol"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00043426-199302000-00013","volume":"15","author":"K Sugita","year":"1993","unstructured":"Sugita K, Furukawa T, Tsuchida M, Okawa Y, Nakazawa S, Akatsuka J, Ohiram M, Nishimura K (1993) High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma. Am J Pediatr Hematol Oncol 15: 99","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1182\/blood.V82.9.2920.2920","volume":"82","author":"DS Synder","year":"1993","unstructured":"Synder DS, Chao NJ, Amylon MD, Taguchi J, Long GD, Negrin RS, Nademanee AP, O'Donnell MR, Schmidt GM, Stein AS, Parker PM, Smith EP, Stepan DE, Molina A, Lipsett JA, Hoppe RT, Niland JC, Dagis AC, Wong RM, Forman SJ, Blume KG (1993) Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 82: 2920","journal-title":"Blood"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199309233291302","volume":"329","author":"MJ Thirman","year":"1933","unstructured":"Thirman MJ, Gill HJ, Burnett RC, Mbngkollo D, McCabe NR, Kobayashi H, Poel SZ-D, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, LeBeau MM, Diaz MO, Rowley JD (1933) Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 329: 909","journal-title":"N Engl J Med"},{"key":"CR81","first-page":"581","volume":"71","author":"GL Wampler","year":"1987","unstructured":"Wampler GL, Carter GH Jr, Campbell ED, Goldman DI (1987) Demonstration of a schedule dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia. Cancer Treat Rep 71: 581","journal-title":"Cancer Treat Rep"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1200\/JCO.1993.11.2.209","volume":"11","author":"NJ Winick","year":"1993","unstructured":"Winick NJ, McKenna RW, Shuster JJ, Schneider NR, Borowitz MJ, Bowman WP, Jacaruso D, Kamen BA, Buchanan GR (1993) Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 11: 209","journal-title":"J Clin Oncol"},{"key":"CR83","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1200\/JCO.1993.11.2.271","volume":"2","author":"NJ Winick","year":"1993","unstructured":"Winick NJ, Smith SD, Shuster J, Lauer S, Wharam MD, Land V, Buchanan G, Rivera GK (1993) Treatment of CNS relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 2: 271","journal-title":"J Clin Oncol"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1200\/JCO.1992.10.4.624","volume":"4","author":"MM Wofford","year":"1992","unstructured":"Wofford MM, Smith SD, Shuster JJ, Johnson W, Buchanan GR, Wharam MD, Rivera GK (1992) Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 4: 624","journal-title":"J Clin Oncol"},{"key":"CR85","first-page":"648","volume":"42","author":"JC Yalowich","year":"1982","unstructured":"Yalowich JC, Fry DW, Goldman ID (1982) Teniposide (VM-26) and etoposide (VP-16-213) induced augmentation of methotrexate transport and polyglutamylation in Ehrlich ascites tumor cells in vitro. Cancer Res 42: 648","journal-title":"Cancer Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00684870.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00684870\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00684870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:19:36Z","timestamp":1625012376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00684870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":85,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF00684870"],"URL":"https:\/\/doi.org\/10.1007\/bf00684870","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}